|
||||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: ENSG00000156966 |
Summary for B3GNT7 |
Gene summary |
| Gene information | Ensembl ID | ENSG00000156966 | Gene symbol | B3GNT7 |
| Gene name | UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7 | |
| HGNC | 18811 | |
| Entrez ID | 93010 | |
| Gene type | protein_coding | |
| Synonyms | B3GNT7|beta3GnT7 | |
| UniProtAcc | Q8NFL0 |
Drugs associated with this gene(DrugBank). |
| Gene ID | Gene Symbol | Drug ID | Drug Name | Drug Type |
Cancer therapeutic drugs associated with this gene(NCI). |
| Gene ID | Gene Name | Drug ID | Drug Name | Drug Type | Cancer |
Top |
Structure and expression level for B3GNT7 |
AS events and RNA A-to-I editing events of the gene in TCGA based on Genvode V22 structure.∗For more information on exon skipping events please check the ExonskipDB database. ∗For more information on exon skipping events please check the CAeditome database. |
Landscape of gene expressions across multiple cancer types. |
Differentially expressed gene analysis between tumor male and tumor female samples. |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
| B3GNT7 | 1.46e+02 | -1.33e+00 | 1.85e-01 | -7.17e+00 | 7.68e-13 | 1.38e-10 | LIHC |
Differentially expressed gene analysis between tumor male and normal male samples. |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
| B3GNT7 | 1.03e+02 | -1.02e+00 | 2.97e-01 | -3.42e+00 | 6.19e-04 | 1.63e-03 | LIHC |
| B3GNT7 | 7.94e+02 | 2.28e+00 | 7.32e-01 | 3.11e+00 | 1.87e-03 | 5.85e-03 | CHOL |
Differentially expressed gene analysis between tumor female and normal female samples. |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
| B3GNT7 | 3.62e+03 | -2.88e+00 | 7.43e-01 | -3.87e+00 | 1.07e-04 | 5.08e-04 | READ |
Top |
Sex-biased somatic mutation for B3GNT7 |
| ∗For more information on exon skipping events please check the ExonskipDB database. |
| Gene ID | Cancer Type | Hugo Symbol | Male | Female | pval | or | ci.up | ci.low | adjPval |
Top |
DNA methylation with beta values for B3GNT7 |
Landscape of DNA methylation across multiple cancer types. |
Differentially expressed CpG sites between male tumor and female tumor patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
| BRCA | cg08202287 | chr2:231394570 | CGI:chr2:231395389-231396423 | promoter | 7.39e-01 | 8.42e-01 | -2.85e+00 | 4.36e-03 | 1.92e-02 | -1.03e-01 |
| LIHC | cg26146617 | chr2:231395594 | CGI:chr2:231395389-231396423 | UTR,promoter,exon,gene body | 3.02e-01 | 4.10e-01 | -3.47e+00 | 5.21e-04 | 2.36e-03 | -1.08e-01 |
| KIRP | cg09004241 | chr2:231394720 | CGI:chr2:231395389-231396423 | promoter | 5.65e-01 | 4.52e-01 | 4.92e+00 | 8.62e-07 | 9.37e-06 | 1.14e-01 |
| CHOL | cg09004241 | chr2:231394720 | CGI:chr2:231395389-231396423 | promoter | 6.38e-01 | 5.08e-01 | 2.16e+00 | 3.04e-02 | 4.07e-02 | 1.30e-01 |
Differentially expressed CpG sites between male tumor and male normal patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
| KIRC | cg26146617 | chr2:231395594 | CGI:chr2:231395389-231396423 | UTR,promoter,exon,gene body | 1.60e-01 | 3.16e-02 | 4.59e+00 | 4.51e-06 | 1.35e-05 | 1.29e-01 |
| KIRC | cg13952656 | chr2:231396051 | CGI:chr2:231395389-231396423 | promoter,gene body | 1.47e-01 | 1.70e-02 | 5.50e+00 | 3.69e-08 | 2.15e-07 | 1.30e-01 |
| KIRC | cg08202287 | chr2:231394570 | CGI:chr2:231395389-231396423 | promoter | 6.27e-01 | 7.53e-01 | -4.77e+00 | 1.87e-06 | 6.27e-06 | -1.25e-01 |
| KIRC | cg05835018 | chr2:231396073 | CGI:chr2:231395389-231396423 | promoter,gene body | 2.11e-01 | 1.09e-01 | 3.55e+00 | 3.86e-04 | 6.70e-04 | 1.02e-01 |
| HNSC | cg17016266 | chr2:231396527 | CGI:chr2:231395389-231396423 | promoter,gene body | 6.08e-01 | 7.67e-01 | -2.66e+00 | 7.70e-03 | 1.03e-02 | -1.59e-01 |
| LUSC | cg20954977 | chr2:231395405 | CGI:chr2:231395389-231396423 | promoter | 3.96e-01 | 4.98e-01 | -2.66e+00 | 7.78e-03 | 1.14e-02 | -1.02e-01 |
| BLCA | cg08202287 | chr2:231394570 | CGI:chr2:231395389-231396423 | promoter | 6.67e-01 | 8.15e-01 | -3.54e+00 | 4.04e-04 | 1.13e-03 | -1.48e-01 |
| BLCA | cg09004241 | chr2:231394720 | CGI:chr2:231395389-231396423 | promoter | 4.47e-01 | 5.57e-01 | -2.97e+00 | 3.01e-03 | 5.42e-03 | -1.10e-01 |
| BLCA | cg17016266 | chr2:231396527 | CGI:chr2:231395389-231396423 | promoter,gene body | 4.93e-01 | 7.74e-01 | -2.11e+00 | 3.51e-02 | 3.80e-02 | -2.81e-01 |
| LIHC | cg06745030 | chr2:231395428 | CGI:chr2:231395389-231396423 | promoter | 6.47e-01 | 4.47e-01 | 4.43e+00 | 9.32e-06 | 2.57e-05 | 2.00e-01 |
| LIHC | cg26146617 | chr2:231395594 | CGI:chr2:231395389-231396423 | UTR,promoter,exon,gene body | 4.10e-01 | 1.43e-01 | 3.96e+00 | 7.57e-05 | 1.62e-04 | 2.67e-01 |
| LIHC | cg09004241 | chr2:231394720 | CGI:chr2:231395389-231396423 | promoter | 4.95e-01 | 6.37e-01 | -4.15e+00 | 3.30e-05 | 7.78e-05 | -1.42e-01 |
| LIHC | cg20034202 | chr2:231395425 | CGI:chr2:231395389-231396423 | promoter | 6.38e-01 | 4.53e-01 | 5.27e+00 | 1.36e-07 | 6.82e-07 | 1.85e-01 |
| LIHC | cg05835018 | chr2:231396073 | CGI:chr2:231395389-231396423 | promoter,gene body | 3.20e-01 | 1.79e-01 | 2.63e+00 | 8.57e-03 | 1.06e-02 | 1.41e-01 |
| CHOL | cg06745030 | chr2:231395428 | CGI:chr2:231395389-231396423 | promoter | 3.18e-01 | 5.19e-01 | -2.14e+00 | 3.25e-02 | 3.87e-02 | -2.00e-01 |
| CHOL | cg08202287 | chr2:231394570 | CGI:chr2:231395389-231396423 | promoter | 7.43e-01 | 8.63e-01 | -2.73e+00 | 6.38e-03 | 1.82e-02 | -1.21e-01 |
| CHOL | cg09004241 | chr2:231394720 | CGI:chr2:231395389-231396423 | promoter | 5.08e-01 | 6.33e-01 | -2.21e+00 | 2.70e-02 | 3.50e-02 | -1.25e-01 |
| CHOL | cg20954977 | chr2:231395405 | CGI:chr2:231395389-231396423 | promoter | 4.73e-01 | 7.75e-01 | -2.58e+00 | 9.87e-03 | 2.15e-02 | -3.01e-01 |
Differentially expressed CpG sites between female tumor and female normal patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
| BRCA | cg06745030 | chr2:231395428 | CGI:chr2:231395389-231396423 | promoter | 3.30e-01 | 1.67e-01 | 6.99e+00 | 2.69e-12 | 7.98e-12 | 1.63e-01 |
| BRCA | cg13952656 | chr2:231396051 | CGI:chr2:231395389-231396423 | promoter,gene body | 1.40e-01 | 2.36e-02 | 9.26e+00 | 2.13e-20 | 1.19e-19 | 1.17e-01 |
| BRCA | cg12162377 | chr2:231396296 | CGI:chr2:231395389-231396423 | promoter,gene body | 3.27e-01 | 9.52e-02 | 6.98e+00 | 2.98e-12 | 8.82e-12 | 2.32e-01 |
| BRCA | cg04286697 | chr2:231394912 | CGI:chr2:231395389-231396423 | promoter | 6.70e-01 | 5.47e-01 | 8.13e+00 | 4.17e-16 | 1.66e-15 | 1.23e-01 |
| BRCA | cg20034202 | chr2:231395425 | CGI:chr2:231395389-231396423 | promoter | 3.87e-01 | 2.70e-01 | 7.10e+00 | 1.23e-12 | 3.75e-12 | 1.17e-01 |
| BRCA | cg05835018 | chr2:231396073 | CGI:chr2:231395389-231396423 | promoter,gene body | 1.95e-01 | 9.13e-02 | 6.06e+00 | 1.38e-09 | 3.31e-09 | 1.04e-01 |
| BRCA | cg17016266 | chr2:231396527 | CGI:chr2:231395389-231396423 | promoter,gene body | 5.95e-01 | 7.42e-01 | -3.68e+00 | 2.34e-04 | 3.34e-04 | -1.47e-01 |
| KIRC | cg09004241 | chr2:231394720 | CGI:chr2:231395389-231396423 | promoter | 5.06e-01 | 3.81e-01 | 2.27e+00 | 2.34e-02 | 3.00e-02 | 1.25e-01 |
| HNSC | cg09004241 | chr2:231394720 | CGI:chr2:231395389-231396423 | promoter | 4.22e-01 | 3.08e-01 | 2.60e+00 | 9.28e-03 | 1.79e-02 | 1.14e-01 |
| HNSC | cg04286697 | chr2:231394912 | CGI:chr2:231395389-231396423 | promoter | 5.43e-01 | 3.90e-01 | 2.56e+00 | 1.06e-02 | 1.92e-02 | 1.53e-01 |
| HNSC | cg20954977 | chr2:231395405 | CGI:chr2:231395389-231396423 | promoter | 5.41e-01 | 3.77e-01 | 2.14e+00 | 3.25e-02 | 3.74e-02 | 1.64e-01 |
| HNSC | cg20034202 | chr2:231395425 | CGI:chr2:231395389-231396423 | promoter | 3.87e-01 | 2.74e-01 | 2.04e+00 | 4.18e-02 | 4.40e-02 | 1.13e-01 |
| COAD | cg04286697 | chr2:231394912 | CGI:chr2:231395389-231396423 | promoter | 5.09e-01 | 3.79e-01 | 2.88e+00 | 3.99e-03 | 8.07e-03 | 1.30e-01 |
| KIRP | cg04286697 | chr2:231394912 | CGI:chr2:231395389-231396423 | promoter | 7.16e-01 | 5.70e-01 | 2.72e+00 | 6.47e-03 | 1.26e-02 | 1.45e-01 |
Top |
Exon skipping events with PSI in TCGA for B3GNT7 |
| ∗Please access ExonSkipDB for exon skipping annotation. |
Differentially expressed exon skipping events between male tumor and female tumor patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
Differentially expressed exon skipping events between male tumor and male normal patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
Differentially expressed exon skipping events between female tumor and female normal patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
Top |
RNA A-to-I editing events in TCGA for B3GNT7 |
| ∗Please access CAeditome for RNA editing annotation. |
Differentially expressed RNA editing events between male tumor and female tumor patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
Differentially expressed RNA editing events between male tumor and male normal patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
Differentially expressed RNA editing events between female tumor and female normal patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
Protein coding RNA editing(s). |
| Editing Position | Variant Type | Gene Symbol | Transcript ID | NTchange | AAchange |
Top |
Sex-biased TF-Gene network for B3GNT7 |
TFs related to B3GNT7.∗The female-biased TF-gene edges were identified if Female_Edge_threshold>0.98 and Male_Edge_threshold<=0.98. ∗The male-biased TF-gene edges were identified if Male_Edge_threshold>0.98 and Female_Edge_threshold<=0.98. |
| Cancer Type | TF | Target Gene | Male Edge Score | Male Edge Threshold | Female Edge Score | Female Edge Threshold | Type |
B3GNT7 related gene.∗Only the gene encode TF might with this result. ∗For more information please check Sex-biased TF-Coding gene network. |
Top |
Sex-biased RBP-ES network for B3GNT7 |
RBPs related to ES in B3GNT7.∗The female-biased RBP-ES edges were identified if Female_Edge_threshold>0.98 and Male_Edge_threshold<=0.98. ∗The male-biased RBP-ES edges were identified if Male_Edge_threshold>0.98 and Female_Edge_threshold<=0.98. |
| Cancer Type | RBP | Target ES | Male Edge Score | Male Edge Threshold | Female Edge Score | Female Edge Threshold | Type |
B3GNT7 related ES.∗Only the gene encode RBP might with this result. ∗For more information please check Sex-biased RBP-ES network in cancer. |
Top |
Sex-biased CeRNA regulation of gene |
Sex-biased CeRNA regulation of gene. |
| Gene ID | ceRNA(lncRNA-miRNA-mRNA) | Group | Cancer Type |
Top |
Sex-biased eQTL regulation of gene |
Sex-biased eQTL regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| eQTL | Description |
Male-specific eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Effect Score | FDR | Cancer Type | Biased Type |
| rs369887047 | chr2:226574013:G:A | - | 0.0764266716842156 | 0.0247213480221322 | LGG | Female-baised eQTL |
| rs76231041 | chr2:226805223:G:A | - | 0.189325807457406 | 0.000122408085107668 | BLCA | Female-baised eQTL |
| rs77110085 | chr2:235120698:T:G | - | 0.185572333873092 | 0.000347345042846735 | BLCA | Female-baised eQTL |
| rs78300956 | chr2:235122427:C:A | - | 0.185572333873092 | 0.000347345042846735 | BLCA | Female-baised eQTL |
| rs72971458 | chr2:235122516:C:T | - | 0.185572333873092 | 0.000347345042846735 | BLCA | Female-baised eQTL |
| rs11684589 | chr2:231389474:G:T | - | 0.118299015001298 | 0.00393630986387404 | BLCA | Female-baised eQTL |
| rs9283540 | chr2:227200450:C:G | - | 0.0923293968604105 | 0.0389283714975273 | BLCA | Female-baised eQTL |
| rs3769647 | chr2:226794867:G:C | - | 0.102248741781572 | 0.0479469750346558 | BLCA | Female-baised eQTL |
| rs7420193 | chr2:233702877:C:G | - | 0.103905613465292 | 0.000479556615448972 | LUAD | Female-baised eQTL |
| rs4663326 | chr2:233707925:A:G | - | 0.105080563003141 | 0.0012894638258037 | LUAD | Female-baised eQTL |
| rs2013030 | chr2:233712394:A:G | - | 0.104212979344383 | 0.001501810054866 | LUAD | Female-baised eQTL |
| rs4663325 | chr2:233707711:C:T | - | 0.0853461005593282 | 0.00239738737572755 | LUAD | Female-baised eQTL |
| rs62191898 | chr2:233708719:T:C | - | 0.0853461005593282 | 0.00239738737572755 | LUAD | Female-baised eQTL |
| rs4663327 | chr2:233708986:G:A | - | 0.0853461005593282 | 0.00239738737572755 | LUAD | Female-baised eQTL |
| rs3732219 | chr2:233718602:C:T | - | 0.0933800963801568 | 0.00304166002972348 | LUAD | Female-baised eQTL |
| rs3732218 | chr2:233718658:G:A | - | 0.0933800963801568 | 0.00304166002972348 | LUAD | Female-baised eQTL |
| rs2885295 | chr2:233711220:T:A | - | 0.09148297502739 | 0.00386773500383228 | LUAD | Female-baised eQTL |
| rs28898595 | chr2:233711887:T:C | - | 0.09148297502739 | 0.00386773500383228 | LUAD | Female-baised eQTL |
| rs28898596 | chr2:233711994:G:A | - | 0.09148297502739 | 0.00386773500383228 | LUAD | Female-baised eQTL |
| rs3893334 | chr2:233712271:C:T | - | 0.09148297502739 | 0.00386773500383228 | LUAD | Female-baised eQTL |
| rs4663945 | chr2:233714471:G:A | - | 0.096293391134442 | 0.00411501116512642 | LUAD | Female-baised eQTL |
| rs2013018 | chr2:233712511:T:C | - | 0.0907738814623562 | 0.00435131765274167 | LUAD | Female-baised eQTL |
| rs5020121 | chr2:233712623:C:T | - | 0.0907738814623562 | 0.00435131765274167 | LUAD | Female-baised eQTL |
| rs4556969 | chr2:233712758:C:T | - | 0.0907738814623562 | 0.00435131765274167 | LUAD | Female-baised eQTL |
| rs3755323 | chr2:233713134:T:C | - | 0.0907738814623562 | 0.00435131765274167 | LUAD | Female-baised eQTL |
| rs3755322 | chr2:233713141:C:G | - | 0.0907738814623562 | 0.00435131765274167 | LUAD | Female-baised eQTL |
| rs3755321 | chr2:233713179:T:C | - | 0.0907738814623562 | 0.00435131765274167 | LUAD | Female-baised eQTL |
| rs3755320 | chr2:233713415:C:A | - | 0.0907738814623562 | 0.00435131765274167 | LUAD | Female-baised eQTL |
| rs12475068 | chr2:233713464:C:G | - | 0.0907738814623562 | 0.00435131765274167 | LUAD | Female-baised eQTL |
| rs17868333 | chr2:233713636:C:T | - | 0.0907738814623562 | 0.00435131765274167 | LUAD | Female-baised eQTL |
| rs2012736 | chr2:233713733:C:A | - | 0.0907738814623562 | 0.00435131765274167 | LUAD | Female-baised eQTL |
| rs17862868 | chr2:233713736:G:C | - | 0.0907738814623562 | 0.00435131765274167 | LUAD | Female-baised eQTL |
| rs3892170 | chr2:233713766:G:C | - | 0.0907738814623562 | 0.00435131765274167 | LUAD | Female-baised eQTL |
| rs17862870 | chr2:233714096:G:A | - | 0.0907738814623562 | 0.00435131765274167 | LUAD | Female-baised eQTL |
| rs17862871 | chr2:233715728:C:T | - | 0.0907738814623562 | 0.00435131765274167 | LUAD | Female-baised eQTL |
| rs17868334 | chr2:233716171:A:G | - | 0.0907738814623562 | 0.00435131765274167 | LUAD | Female-baised eQTL |
| rs17863791 | chr2:233716238:T:C | - | 0.0907738814623562 | 0.00435131765274167 | LUAD | Female-baised eQTL |
| rs17864696 | chr2:233716548:A:C | - | 0.0907738814623562 | 0.00435131765274167 | LUAD | Female-baised eQTL |
| rs17874943 | chr2:233716593:A:G | - | 0.0907738814623562 | 0.00435131765274167 | LUAD | Female-baised eQTL |
| rs28898605 | chr2:233716848:A:G | - | 0.0907738814623562 | 0.00435131765274167 | LUAD | Female-baised eQTL |
| rs3806595 | chr2:233717072:T:A | - | 0.0907738814623562 | 0.00435131765274167 | LUAD | Female-baised eQTL |
| rs3806594 | chr2:233717244:T:C | - | 0.0907738814623562 | 0.00435131765274167 | LUAD | Female-baised eQTL |
| rs3806593 | chr2:233717273:A:G | - | 0.0907738814623562 | 0.00435131765274167 | LUAD | Female-baised eQTL |
| rs3806591 | chr2:233717553:T:C | - | 0.0907738814623562 | 0.00435131765274167 | LUAD | Female-baised eQTL |
| rs3732221 | chr2:233718364:C:T | - | 0.0907738814623562 | 0.00435131765274167 | LUAD | Female-baised eQTL |
| rs3732220 | chr2:233718402:G:A | - | 0.0907738814623562 | 0.00435131765274167 | LUAD | Female-baised eQTL |
| rs17868335 | chr2:233716337:C:A | - | 0.0906904942383233 | 0.00444019004110653 | LUAD | Female-baised eQTL |
| rs17863792 | chr2:233716480:G:A | - | 0.0876188369043587 | 0.00689686313725402 | LUAD | Female-baised eQTL |
| rs2011425 | chr2:233718962:T:G | - | 0.0894195354708896 | 0.00770524466600057 | LUAD | Female-baised eQTL |
| rs12477216 | chr2:233715021:C:T | - | 0.0845630716149807 | 0.0135549518728477 | LUAD | Female-baised eQTL |
| rs2013021 | chr2:233712440:C:T | - | 0.0810967248488326 | 0.0154458254445913 | LUAD | Female-baised eQTL |
| rs17862878 | chr2:233753302:G:A | - | 0.0861134915767547 | 0.0265664964103523 | LUAD | Female-baised eQTL |
| rs893359 | chr2:224072155:A:C | - | -0.0797321266594245 | 0.0487404303591347 | LUAD | Female-baised eQTL |
| rs1448295 | chr2:223094376:C:T | - | -0.111096584145828 | 0.000678736701181936 | COAD | Female-baised eQTL |
| rs11891864 | chr2:223102251:T:G | - | -0.0992476609917803 | 0.0130554915754712 | COAD | Female-baised eQTL |
| rs11891896 | chr2:223102299:T:A | - | -0.0992476609917803 | 0.0130554915754712 | COAD | Female-baised eQTL |
| rs1448308 | chr2:223129943:G:T | - | -0.0989475994813478 | 0.0162927444918587 | COAD | Female-baised eQTL |
| rs5012753 | chr2:223137926:T:A | - | -0.0957161432594884 | 0.0214615322994571 | COAD | Female-baised eQTL |
| rs5012752 | chr2:223137928:A:T | - | -0.0957161432594884 | 0.0214615322994571 | COAD | Female-baised eQTL |
| rs4521028 | chr2:223137968:C:T | - | -0.0957161432594884 | 0.0214615322994571 | COAD | Female-baised eQTL |
| rs4429465 | chr2:223138062:T:C | - | -0.0957161432594884 | 0.0214615322994571 | COAD | Female-baised eQTL |
| rs2218666 | chr2:223124519:T:C | - | -0.0908300621068105 | 0.0257847953247839 | COAD | Female-baised eQTL |
| rs981424 | chr2:223124550:A:G | - | -0.0908300621068105 | 0.0257847953247839 | COAD | Female-baised eQTL |
| rs1118024 | chr2:223139906:A:G | - | -0.0937414804332707 | 0.0270235070611043 | COAD | Female-baised eQTL |
| rs1448312 | chr2:223122311:C:T | - | -0.0856568349645543 | 0.0428548368722586 | COAD | Female-baised eQTL |
| rs1448313 | chr2:223122134:A:G | - | -0.083498570219431 | 0.0488589389227466 | COAD | Female-baised eQTL |
| rs6761103 | chr2:223123039:G:A | - | -0.083498570219431 | 0.0488589389227466 | COAD | Female-baised eQTL |
| rs4234045 | chr2:223124431:G:A | - | -0.083498570219431 | 0.0488589389227466 | COAD | Female-baised eQTL |
| rs981423 | chr2:223124857:A:T | - | -0.083498570219431 | 0.0488589389227466 | COAD | Female-baised eQTL |
| rs6436381 | chr2:223126514:C:T | - | -0.083498570219431 | 0.0488589389227466 | COAD | Female-baised eQTL |
| rs7600741 | chr2:223126704:C:A | - | -0.083498570219431 | 0.0488589389227466 | COAD | Female-baised eQTL |
| rs6436382 | chr2:223126885:A:G | - | -0.083498570219431 | 0.0488589389227466 | COAD | Female-baised eQTL |
| rs6436383 | chr2:223126923:A:T | - | -0.083498570219431 | 0.0488589389227466 | COAD | Female-baised eQTL |
| rs4449122 | chr2:223127010:C:T | - | -0.083498570219431 | 0.0488589389227466 | COAD | Female-baised eQTL |
| rs6756271 | chr2:223127339:G:A | - | -0.083498570219431 | 0.0488589389227466 | COAD | Female-baised eQTL |
| rs6756613 | chr2:223127597:G:A | - | -0.083498570219431 | 0.0488589389227466 | COAD | Female-baised eQTL |
| rs6714739 | chr2:223127860:T:G | - | -0.083498570219431 | 0.0488589389227466 | COAD | Female-baised eQTL |
| rs6436385 | chr2:223128052:A:G | - | -0.083498570219431 | 0.0488589389227466 | COAD | Female-baised eQTL |
| rs1448307 | chr2:223130110:G:T | - | -0.083498570219431 | 0.0488589389227466 | COAD | Female-baised eQTL |
| rs6743049 | chr2:223131047:A:G | - | -0.083498570219431 | 0.0488589389227466 | COAD | Female-baised eQTL |
| rs6436387 | chr2:223131265:G:A | - | -0.083498570219431 | 0.0488589389227466 | COAD | Female-baised eQTL |
| rs6436388 | chr2:223131432:G:A | - | -0.083498570219431 | 0.0488589389227466 | COAD | Female-baised eQTL |
| rs7566720 | chr2:223131905:C:G | - | -0.083498570219431 | 0.0488589389227466 | COAD | Female-baised eQTL |
| rs7569750 | chr2:223132093:G:A | - | -0.083498570219431 | 0.0488589389227466 | COAD | Female-baised eQTL |
| rs9636340 | chr2:223132915:T:C | - | -0.083498570219431 | 0.0488589389227466 | COAD | Female-baised eQTL |
| rs13028040 | chr2:223134497:C:T | - | -0.083498570219431 | 0.0488589389227466 | COAD | Female-baised eQTL |
| rs2894491 | chr2:223135830:A:G | - | -0.083498570219431 | 0.0488589389227466 | COAD | Female-baised eQTL |
| rs7565252 | chr2:223136423:G:A | - | -0.083498570219431 | 0.0488589389227466 | COAD | Female-baised eQTL |
| rs4674744 | chr2:223137192:T:G | - | -0.083498570219431 | 0.0488589389227466 | COAD | Female-baised eQTL |
| rs2034374 | chr2:223137637:C:A | - | -0.083498570219431 | 0.0488589389227466 | COAD | Female-baised eQTL |
| rs6758018 | chr2:223122904:C:T | - | -0.0833334974933076 | 0.0498915280459325 | COAD | Female-baised eQTL |
Female-specific eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Effect Score | FDR | Cancer Type | Biased Type |
| rs16823258 | chr2:227145829:T:C | - | 0.195759292080507 | 0.00366841277809635 | PCPG | Male-baised eQTL |
| rs10933002 | chr2:223237365:T:G | - | 0.042182732590655 | 0.0291702674865344 | LIHC | Male-baised eQTL |
| rs79823552 | chr2:223237924:C:G | - | 0.0421144638073908 | 0.0296265104688628 | LIHC | Male-baised eQTL |
| rs80031591 | chr2:223263069:C:T | - | 0.0388074711455763 | 0.0485480330704116 | LIHC | Male-baised eQTL |
| rs2083575 | chr2:233236434:T:C | - | 0.0679506188893621 | 0.00223903693511138 | LUSC | Male-baised eQTL |
| rs35661897 | chr2:226469122:A:G | - | 0.040733132524333 | 0.0433577851266722 | LUSC | Male-baised eQTL |
| rs1250907 | chr2:223576479:T:C | - | -0.0615914027448493 | 0.00140843522197566 | LGG | Male-baised eQTL |
| rs78822929 | chr2:223547884:G:A | - | 0.0608955189217616 | 0.00184646847908593 | LGG | Male-baised eQTL |
| rs721358 | chr2:223502238:C:T | - | 0.0579635238025619 | 0.00616633896956062 | LGG | Male-baised eQTL |
| rs4075306 | chr2:233065010:C:A | - | 0.0684262318991374 | 0.00668626323603755 | LGG | Male-baised eQTL |
| rs11674347 | chr2:233076678:A:G | - | 0.063520640319065 | 0.00968650660670785 | LGG | Male-baised eQTL |
| rs73094968 | chr2:233068412:G:A | - | 0.0648736623901826 | 0.0105164500950312 | LGG | Male-baised eQTL |
| rs73094970 | chr2:233068438:C:T | - | 0.0648736623901826 | 0.0105164500950312 | LGG | Male-baised eQTL |
| rs13387403 | chr2:223543836:G:A | - | 0.0495026521035581 | 0.0111421973434724 | LGG | Male-baised eQTL |
| rs60486020 | chr2:233066962:G:A | - | 0.0646939831401576 | 0.0111789893256482 | LGG | Male-baised eQTL |
| rs13391589 | chr2:223504687:C:T | - | 0.0515339546571396 | 0.0156621766970348 | LGG | Male-baised eQTL |
| rs10208773 | chr2:223505963:G:T | - | 0.0514833806742176 | 0.0159860339197148 | LGG | Male-baised eQTL |
| rs16864919 | chr2:223543350:C:T | - | 0.0467387841800199 | 0.0193314076182864 | LGG | Male-baised eQTL |
| rs7607430 | chr2:223520690:T:A | - | 0.0479936813784957 | 0.0206803449967737 | LGG | Male-baised eQTL |
| rs7566745 | chr2:223520691:A:T | - | 0.0479936813784957 | 0.0206803449967737 | LGG | Male-baised eQTL |
| rs13425912 | chr2:223511970:A:G | - | 0.0495722034633687 | 0.0207448540947979 | LGG | Male-baised eQTL |
| rs10168404 | chr2:223543103:C:A | - | 0.0459997316977148 | 0.0221309280578471 | LGG | Male-baised eQTL |
| rs10184508 | chr2:223518587:C:A | - | 0.0472670125217108 | 0.0235051346751896 | LGG | Male-baised eQTL |
| rs7590185 | chr2:223535205:T:A | - | 0.049460073300417 | 0.0265796634572658 | LGG | Male-baised eQTL |
| rs2396008 | chr2:223532164:T:C | - | 0.048715657921531 | 0.0293274837182369 | LGG | Male-baised eQTL |
| rs1439929 | chr2:223533281:A:C | - | 0.048715657921531 | 0.0293274837182369 | LGG | Male-baised eQTL |
| rs1439928 | chr2:223534022:A:C | - | 0.048715657921531 | 0.0293274837182369 | LGG | Male-baised eQTL |
| rs75618801 | chr2:223519400:T:C | - | 0.0487180659537211 | 0.0293831321013412 | LGG | Male-baised eQTL |
| rs7569847 | chr2:223521144:A:G | - | 0.0487180659537211 | 0.0293831321013412 | LGG | Male-baised eQTL |
| rs7608631 | chr2:223524765:G:T | - | 0.0487180659537211 | 0.0293831321013412 | LGG | Male-baised eQTL |
| rs7558973 | chr2:223525462:G:C | - | 0.0487180659537211 | 0.0293831321013412 | LGG | Male-baised eQTL |
| rs6751034 | chr2:223527344:G:T | - | 0.0487180659537211 | 0.0293831321013412 | LGG | Male-baised eQTL |
| rs733939 | chr2:223528988:C:T | - | 0.0487180659537211 | 0.0293831321013412 | LGG | Male-baised eQTL |
| rs6436413 | chr2:223529405:T:C | - | 0.0487180659537211 | 0.0293831321013412 | LGG | Male-baised eQTL |
| rs893766 | chr2:223529788:C:T | - | 0.0487180659537211 | 0.0293831321013412 | LGG | Male-baised eQTL |
| rs7571417 | chr2:223530248:T:C | - | 0.0487180659537211 | 0.0293831321013412 | LGG | Male-baised eQTL |
| rs6436414 | chr2:223531173:G:A | - | 0.0487180659537211 | 0.0293831321013412 | LGG | Male-baised eQTL |
| rs10498150 | chr2:223512316:C:T | - | 0.0475975752223827 | 0.0300802587188532 | LGG | Male-baised eQTL |
| rs11677752 | chr2:233065988:C:G | - | 0.0583578142021052 | 0.0308731709032926 | LGG | Male-baised eQTL |
| rs7597404 | chr2:223512869:T:A | - | 0.0456603606945026 | 0.0319362174100204 | LGG | Male-baised eQTL |
| rs4533463 | chr2:223513765:G:A | - | 0.0478787227921938 | 0.0333588812741626 | LGG | Male-baised eQTL |
| rs7578231 | chr2:223516373:G:A | - | 0.0478787227921938 | 0.0333588812741626 | LGG | Male-baised eQTL |
| rs1009270 | chr2:223517550:A:G | - | 0.0478787227921938 | 0.0333588812741626 | LGG | Male-baised eQTL |
| rs4674790 | chr2:223518149:G:A | - | 0.0478787227921938 | 0.0333588812741626 | LGG | Male-baised eQTL |
| rs13429507 | chr2:223546544:C:A | - | 0.0428468962350313 | 0.0442090484136414 | LGG | Male-baised eQTL |
| rs58517035 | chr2:224091433:C:T | - | -0.0938857515188424 | 0.0116528027578538 | COAD | Male-baised eQTL |
| rs1453661 | chr2:224080761:G:C | - | -0.0874840542583215 | 0.018718693653716 | COAD | Male-baised eQTL |
| rs10498157 | chr2:224086849:C:T | - | -0.0873790256088325 | 0.0189275919521613 | COAD | Male-baised eQTL |
| rs2123715 | chr2:224089484:T:G | - | -0.0873790256088325 | 0.0189275919521613 | COAD | Male-baised eQTL |
| rs1377609 | chr2:224081315:A:G | - | -0.0779836462307326 | 0.0367481616316415 | COAD | Male-baised eQTL |
| rs10184775 | chr2:224085423:A:G | - | -0.0794489136432095 | 0.0374846695025897 | COAD | Male-baised eQTL |
| rs2325806 | chr2:237594916:C:G | - | -0.037649731551711 | 0.0463219542520775 | COAD | Male-baised eQTL |
Opposite sex-biased eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Male Effect | Male FDR | Female Effect | Female FDR | Sex-biased Gene in Cancer | Cancer Type |
Top |
Sex-biased eQTM regulation of gene |
Sex-biased eQTM regulation of gene (The figures only show the pairs with FDR<1e-5. For more information please check the below table). |
Male-specific eQTM regulation. |
| CpG Site | CpG Postion | Position to Gene | Effect Score | FDR | Cor.r | Cor.Pvalue | Cancer Type |
| cg04286697 | chr2:231394912 | promoter | -0.432652738283535 | 1.02548380477788e-05 | -0.5055022754212838 | 1.1027064709614504e-07 | PAAD |
Female-specific eQTM regulation. |
| CpG Site | CpG Postion | Position to Gene | Effect Score | FDR | Cor.r | Cor.Pvalue | Cancer Type |
| cg17016266 | chr2:231396527 | gene,promoter | -0.43540382007924 | 1.33034602358313e-06 | -0.6531728078808626 | 8.866381848782046e-10 | KIRP |
Opposite sex-biased eQTM regulation. |
| CpG Site | CpG Postion | CpG Island | Position to Gene | Male Effect | Male FDR | Female Effect | Female FDR | Male Cor | Male P-value | Female Cor | Female P-value | Sex-biased Coding Gene | Cancer Type |
Top |
Sex-biased sQTL regulation of gene |
Sex-biased sQTL regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| sQTL | Description |
Male-specific sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Effect Score | FDR | Cancer Type | Biased Type |
Female-specific sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Effect Score | FDR | Cancer Type | Biased Type |
Opposite sex-biased sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Male Effect | Male FDR | Female Effect | Female FDR | Cancer Type |
Top |
Sex-biased sQTM regulation of gene |
Sex-biased sQTM regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| sQTM | Description |
Male-specific sQTM regulation. |
| EX ID | Skipped Exon | CPG Site | CPG Position | Position to EX Events | Effect Score | FDR | Cor.r | Cor.Pvalue | ORF_anno | Cancer Type |
Female-specific sQTM regulation. |
| EX ID | Skipped Exon | CPG Site | CPG Position | Position to EX Events | Effect Score | FDR | Cor.r | Cor.Pvalue | ORF_anno | Cancer Type |
Opposite sex-biased sQTM regulation. |
| EX ID | EX Info | Skipped Exon | CPG Site | CPG Position | CPG Island | Position to EX Events | Male Effect | Male FDR | Female Effect | Female FDR | Male Correlation | Male P-value | Female Correlation | Female P-value | ORF_anno | Cancer Type |
Top |
Related disease information of B3GNT7 |
Diseases associated with this gene (DisGeNET). |
| Gene ID | Gene Symbol | Disease ID | Disease Name | Number of PMID | Source |